Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
27.83
-0.12 (-0.43%)
Streaming Delayed Price
Updated: 10:55 AM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
Next >
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
August 12, 2024
The widely followed growth investor was a buyer at the end of a very volatile trading week.
Via
The Motley Fool
Cathie Wood's Ark Invest Continues Loads Up On $6.05M Worth Of Robinhood Shares Amid Bitcoin Rebound, Dumps Zoom Stock
August 08, 2024
On Thursday, Cathie Wood-led Ark Invest made some significant trades, notably buying Robinhood Markets Inc (NASDAQ:HOOD) and selling Zoom Video Communications Inc (NASDAQ:ZM).
Via
Benzinga
Key Takeaways From Guardant Health Analyst Ratings
August 08, 2024
Via
Benzinga
GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q2 2024
August 07, 2024
GH stock results show that Guardant Health beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat
August 01, 2024
The company expects stronger second-half sales vs. the first half of 2024.
Via
Investor's Business Daily
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 31, 2024
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions.
Via
The Motley Fool
Assessing Guardant Health: Insights From 7 Financial Analysts
July 17, 2024
Via
Benzinga
Where Guardant Health Stands With Analysts
June 28, 2024
Via
Benzinga
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
July 29, 2024
FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-approved blood test as a primary CRC screening option. Shield meets Medicare...
Via
Benzinga
Exposures
Product Safety
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
July 22, 2024
The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them.
Via
InvestorPlace
3 Precision Medicine Stocks Tailoring Treatments
July 21, 2024
With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider.
Via
InvestorPlace
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
July 18, 2024
Via
Benzinga
3 Biotech Moonshots With Imminent Catalyst Potential
July 03, 2024
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
Via
InvestorPlace
Evaluating Guardant Health: Insights From 5 Financial Analysts
May 24, 2024
Via
Benzinga
Key Takeaways From Guardant Health Analyst Ratings
April 24, 2024
Via
Benzinga
Analyst Expectations For Guardant Health's Future
April 05, 2024
Via
Benzinga
The 3 Best Personalized Medicine Stocks to Buy in July 2024
July 03, 2024
Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies.
Via
InvestorPlace
From ‘Sell’ to ‘Strong Buy’: 3 Dramatic Analyst U-Turns to Watch
July 02, 2024
These are three stocks with analyst upgrades worth looking into thanks to their niche specializations and long-term prospects.
Via
InvestorPlace
Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
May 29, 2024
On Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades involving Robinhood Markets Inc (NASDAQ:HOOD), Moderna Inc (NASDAQ:MRNA), Palantir
Via
Benzinga
Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns
May 27, 2024
We're heading into our third year of this raging bull market, and there doesn't appear to be any end in sight for these high-return stocks.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday
May 24, 2024
Via
Benzinga
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
May 24, 2024
FDA panel recommends approval for Guardant Health's Shield blood test for colorectal cancer screening.
Via
Benzinga
Exposures
Product Safety
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
May 24, 2024
The companies are likely to soon battle it out in the colon cancer screening market.
Via
Investor's Business Daily
Exposures
Product Safety
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
May 21, 2024
FDA staff reviewers raise concerns over Guardant Health's experimental Shield blood test for colorectal cancer, citing low sensitivity in detecting certain tumor types. Shield aims to improve early CRC...
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
GH stock results show that Guardant Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
April 22, 2024
Via
Benzinga
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
April 02, 2024
The companies are working to detect colon cancer and precancerous markers in blood and/or stool.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.